Literature DB >> 17710429

The immunohistochemical evaluation of VEGF in placenta biopsies of pregnancies complicated by preeclampsia.

Fuat Akercan1, Teksin Cirpan, M Cosan Terek, H Tayfun Ozcakir, Gulsen Giray, Sermet Sagol, Nedim Karadadas.   

Abstract

OBJECTIVE: The study was designed to determine the protein levels of vascular endothelial growth factor (VEGF) in the placenta biopsies of patients with preeclampsia and compare with normal controls.
DESIGN: Prospective cohort study.
METHODS: The placental biopsies were obtained from ten patients with preeclampsia and ten patients of control group at the time of delivery. Avidin-biotin-peroxidase immunohistochemistry was then performed to identify levels of VEGF protein within the tissue and a semi-quantitative method was devised to score the amount of staining present in the sample. Two histopathologists who were blinded to the groups were asked to score each sample for the intensity of staining and the number of cells stained in a randomly selected per high-power fields of each sample. The resulting "H-score" was computed as a product of intensity and percent of cells stained.
RESULTS: The VEGF expression was significantly higher in placenta biopsies of preeclamptic patients compared to that of controls (271.2 +/- 22.65 vs. 201.9 +/- 12.33, P = 0.000).
CONCLUSION: Immunostaining of VEGF is significantly higher in placenta biopsies of patients with preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17710429     DOI: 10.1007/s00404-007-0430-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  11 in total

1.  Novel expression of EGFL7 in placental trophoblast and endothelial cells and its implication in preeclampsia.

Authors:  Lauretta A Lacko; Micol Massimiani; Jenny L Sones; Romulo Hurtado; Silvia Salvi; Sergio Ferrazzani; Robin L Davisson; Luisa Campagnolo; Heidi Stuhlmann
Journal:  Mech Dev       Date:  2014-04-19       Impact factor: 1.882

2.  Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.

Authors:  Guixiang Chen; Lihong Zhang; Xiaohong Jin; Yunjiao Zhou; Jianying Niu; Jing Chen; Yong Gu
Journal:  Reprod Sci       Date:  2012-09-18       Impact factor: 3.060

3.  Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.

Authors:  Alain F Tanbe; Raouf A Khalil
Journal:  Curr Bioact Compd       Date:  2010-03-01

Review 4.  Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.

Authors:  Stephanie J Sheppard; Raouf A Khalil
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2010-03

5.  Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women.

Authors:  Sarah N Cross; Elena Ratner; Thomas J Rutherford; Peter E Schwartz; Errol R Norwitz
Journal:  Rev Obstet Gynecol       Date:  2012

6.  Neonatal programming by immunological challenge: effects on ovarian function in the adult rat.

Authors:  Xue-Qing Wu; Xiao-Feng Li; Bilu Ye; Neha Popat; Stuart R Milligan; Stafford L Lightman; Kevin T O'Byrne
Journal:  Reproduction       Date:  2010-11-17       Impact factor: 3.906

7.  Transcriptome landscape of the human placenta.

Authors:  Jinsil Kim; Keyan Zhao; Peng Jiang; Zhi-xiang Lu; Jinkai Wang; Jeffrey C Murray; Yi Xing
Journal:  BMC Genomics       Date:  2012-03-27       Impact factor: 3.969

8.  The role of angiogenic, anti-angiogenic and vasoactive factors in pre-eclamptic African women: early- versus late-onset pre-eclampsia.

Authors:  Lucinda Govender; Irene Mackraj; Prem Gathiram; Jack Moodley
Journal:  Cardiovasc J Afr       Date:  2012-04       Impact factor: 1.167

9.  VEGF may contribute to macrophage recruitment and M2 polarization in the decidua.

Authors:  Karen C Wheeler; Manoj K Jena; Bhola S Pradhan; Neha Nayak; Subhendu Das; Chaur-Dong Hsu; David S Wheeler; Kang Chen; Nihar R Nayak
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

10.  The differential expression of Kiss1, MMP9 and angiogenic regulators across the feto-maternal interface of healthy human pregnancies: implications for trophoblast invasion and vessel development.

Authors:  Mushi Matjila; Robert Millar; Zephne van der Spuy; Arieh Katz
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.